Skip to main content

. 1965 Sep;19(3):519–526. doi: 10.1038/bjc.1965.63

The action of protamine derivatives and nitrogen mustard on the growth of the Walker 256 rat carcinoma.

PMCID: PMC2071329 PMID: 5833070

519

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

LISNELL A., MELLGREN J. Effect of heparin, protamine, dicoumarol, streptokinase and epsilon-amino-n-caproic acid on the growth of human cells in vitro. Acta Pathol Microbiol Scand. 1963;57:145–153. doi: 10.1111/j.1699-0463.1963.tb03439.x. [DOI] [PubMed] [Google Scholar]
LUTTON A. TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATE. Lancet. 1964 Apr 4;1(7336):768–769. doi: 10.1016/s0140-6736(64)92889-2. [DOI] [PubMed] [Google Scholar]
MUGGLETON P. W., MACLAREN J. G., DYKE W. J. EFFECT OF PROTAMINE SULPHATE ON EXPERIMENTAL TUMOURS IN MICE. Lancet. 1964 Feb 22;1(7330):409–410. doi: 10.1016/s0140-6736(64)92788-6. [DOI] [PubMed] [Google Scholar]
O'MEARA R. A. Coagulative properties of cancers. Ir J Med Sci. 1958 Oct;394:474–479. [PubMed] [Google Scholar]
RODIN A. E., TURNER F. W., COUVES C. M. INFLUENCE OF ISOLATION PERFUSION WITH AN ALKYLATING AGENT ON THE HISTOPATHOLOGY AND METASTATIC PROPENSITY OF WALKER-256 CARCINOMA. Can J Surg. 1963 Oct;6:489–498. [PubMed] [Google Scholar]
THORNES R. D., O'MEARA R. A. A method of detecting and estimating inhibitors of the cancer coagulative factor. Ir J Med Sci. 1961 Aug;428:361–365. doi: 10.1007/BF02953365. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES